Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,065 across all filing types
Latest filing 2023-09-18 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
CONNECTED TRANSACTION - PROVISION OF LOAN
Capital/Financing Update Classification · 95% confidence The document is an announcement from Uni-Bio Science Group Limited regarding a connected transaction involving the provision of a loan and extension of a previous loan. It details the loan agreement terms, parties involved, reasons for the loan, and implications under the Listing Rules. The document is structured as a formal announcement with no financial statements or detailed financial analysis. It focuses on disclosure of a connected transaction under the Hong Kong Stock Exchange Listing Rules, specifically Chapter 14A, which governs connected transactions. There is no indication that this is a full financial report, audit report, or earnings release. The content fits the category of a Capital/Financing Update as it relates to financing activities (loan provision and extension) and capital structure implications. The document length (13,601 characters) and detailed content support it being a substantive announcement rather than a brief notice or regulatory filing. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-09-18 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 August 2023. It details movements in authorized and issued share capital, share options, and confirmations related to securities issued during the month. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share option movements for a specific month. It does not contain financial statements, earnings data, management discussion, or other report content. It is a regulatory filing reporting share capital movements and confirmations, fitting the category of Regulatory Filings (RNS) as a general regulatory announcement and compliance document that does not fit other specific categories.
2023-09-04 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023' and contains detailed financial data, including revenue, profit, segment results, and management discussion and analysis for the six-month period ending June 30, 2023. It includes unaudited condensed consolidated interim results, key financial highlights, business review, market review, and pipeline progress. The presence of actual financial figures and substantive analysis for a half-year period clearly indicates this is a comprehensive interim financial report rather than a brief announcement or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-08-28 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is an announcement from Uni-Bio Science Group Limited stating the date of a board meeting to approve and publish the interim financial results for the six months ended 30 June 2023. It does not contain the actual interim financial results or substantive financial data, but rather informs about the upcoming approval and publication of such results. The document length is short (1658 characters) and serves as a notice rather than the report itself. According to the 'MENU VS MEAL' rule, this type of announcement is classified as a Report Publication Announcement (RPA).
2023-08-16 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles and functions, including committee memberships, with an effective date of 11 August 2023. There is no financial data, no mention of financial results, no voting results, no legal proceedings, no capital changes, and no report publication announcements. The content is focused on the composition and structure of the board and its committees, which fits the definition of Board/Management Information (MANG). The document length is short and purely informational about board members, not a report or announcement of a report. Therefore, the classification is MANG with high confidence.
2023-08-11 English
APPOINTMENT OF AN EXECUTIVE DIRECTOR
Board/Management Information Classification · 100% confidence The document is an announcement from Uni-Bio Science Group Limited regarding the appointment of an executive director, Ms. Zhang Yanfen, effective from 11 August 2023. It includes biographical details, terms of appointment, and disclosures related to the appointment. There is no financial data, report, or presentation content. The document is clearly about a change in the company's board of directors. Therefore, it fits the category of Board/Management Information (MANG). The document length is 4049 characters, which is consistent with a typical announcement rather than a full report. Hence, the classification is MANG with high confidence.
2023-08-11 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.